Spectral AI, Inc. Class A Common Stock (MDAI) Stock Price
MDAIStock
$1.57−21.11%52W
Market Cap$50.53M
P/E—
PEG Ratio—
Div yield—
Beta1.23
MDAI Share Price Chart
Favorite Metrics
Price vs S&P 500 (26W)-1.37%
Price vs S&P 500 (4W)-4.03%
VGM Score27.17
MDAI Earnings Surprise History
| Quarter | Report date | EPS estimate | EPS actual | Surprise |
|---|---|---|---|---|
| Q4 2025 | -$0.14 | $0.02 | +114.29%(+$0.16) | |
| Q3 2025 | -$0.09 | -$0.13 | -52.94%(-$0.05) | |
| Q2 2025 | -$0.08 | -$0.31 | -287.50%(-$0.23) |
MDAI Analyst Recommendations
May 2026
Jun 2026
Jul 2026
Aug 2026
4.25
4.25
4.25
4.14
Industry Peers — Surgical & Medical Instruments(140)
| Symbol | Value Score | Growth Score | Momentum Score | Price |
|---|---|---|---|---|
MDAISpectral AI, Inc. Class A Common Stock | D | F | D | $1.57 |
| SYKStryker Corporation | C | B | C | $330.69 |
| MMM3M Company | C | D | C | $174.34 |
| BSXBoston Scientific Corp. | C | B | D | $46.84 |
| BDXBecton, Dickinson and Co. | B | D | B | $189.52 |
| MDLNMedline Inc. Class A common stock | C | D | C | $35.28 |
| RMDResMed Inc. | C | B | B | $240.33 |
| DXCMDexCom, Inc. | D | B | B | $90.82 |
| WSTWest Pharmaceutical Services, Inc. | D | C | B | $337.47 |
| SOLVSolventum Corporation | C | C | B | $91.12 |
| BAXBaxter International Inc. | B | D | B | $26.13 |
About Spectral AI, Inc. Class A Common Stock
Spectral AI develops DeepView, an AI-powered diagnostic system that uses proprietary algorithms and multispectral imaging to assess tissue damage and wound healing. The system has received FDA Breakthrough Device Designation and delivers healing assessments in seconds, enabling physicians to make faster, more accurate treatment decisions. By detecting damage invisible to the naked eye, DeepView aims to improve wound treatment outcomes and streamline clinical workflows.